125 related articles for article (PubMed ID: 38746858)
21. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease.
Liang W; Yang Y; Gong S; Wei M; Ma Y; Feng R; Gao J; Liu X; Tu F; Ma W; Yi X; Liang Z; Wang F; Wang L; Chen D; Shu W; Miller BE; Tal-Singer R; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Brightling CE; Chen R; Zhong N; Wang Z
Cell Host Microbe; 2023 Jun; 31(6):1054-1070.e9. PubMed ID: 37207649
[TBL] [Abstract][Full Text] [Related]
22. Eradication of Nontuberculous Mycobacteria in People with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Cohort Study.
Wiesel V; Aviram M; Mei-Zahav M; Dotan M; Prais D; Cohen-Cymberknoh M; Gur M; Bar-Yoseph R; Livnat G; Goldbart A; Hazan G; Hazan I; Golan-Tripto I
J Cyst Fibros; 2024 Jan; 23(1):41-49. PubMed ID: 37173154
[TBL] [Abstract][Full Text] [Related]
23. Awake prone positioning in acute hypoxaemic respiratory failure.
McNicholas BA; Ibarra-Estrada M; Perez Y; Li J; Pavlov I; Kharat A; Vines DL; Roca O; Cosgrave D; Guerin C; Ehrmann S; Laffey JG
Eur Respir Rev; 2023 Jun; 32(168):. PubMed ID: 37137508
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist.
Nichols DP; Morgan SJ; Skalland M; Vo AT; Van Dalfsen JM; Singh SB; Ni W; Hoffman LR; McGeer K; Heltshe SL; Clancy JP; Rowe SM; Jorth P; Singh PK;
J Clin Invest; 2023 May; 133(10):. PubMed ID: 36976651
[TBL] [Abstract][Full Text] [Related]
25. An mRNA Influenza Vaccine - Could It Deliver?
Neuzil KM
N Engl J Med; 2023 Mar; 388(12):1139-1141. PubMed ID: 36947471
[No Abstract] [Full Text] [Related]
26. Risk Factors for Respiratory Viral Infections: A Spotlight on Climate Change and Air Pollution.
Burbank AJ
J Asthma Allergy; 2023; 16():183-194. PubMed ID: 36721739
[TBL] [Abstract][Full Text] [Related]
27. Primary prevention of acute cardiovascular events by influenza vaccination: an observational study.
Davidson JA; Banerjee A; Douglas I; Leyrat C; Pebody R; McDonald HI; Herrett E; Forbes H; Smeeth L; Warren-Gash C
Eur Heart J; 2023 Feb; 44(7):610-620. PubMed ID: 36537199
[TBL] [Abstract][Full Text] [Related]
28. A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.
Arevalo CP; Bolton MJ; Le Sage V; Ye N; Furey C; Muramatsu H; Alameh MG; Pardi N; Drapeau EM; Parkhouse K; Garretson T; Morris JS; Moncla LH; Tam YK; Fan SHY; Lakdawala SS; Weissman D; Hensley SE
Science; 2022 Nov; 378(6622):899-904. PubMed ID: 36423275
[TBL] [Abstract][Full Text] [Related]
29. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study.
Wildenbeest JG; Billard MN; Zuurbier RP; Korsten K; Langedijk AC; van de Ven PM; Snape MD; Drysdale SB; Pollard AJ; Robinson H; Heikkinen T; Cunningham S; O'Neill T; Rizkalla B; Dacosta-Urbieta A; Martinón-Torres F; van Houten MA; Bont LJ;
Lancet Respir Med; 2023 Apr; 11(4):341-353. PubMed ID: 36372082
[TBL] [Abstract][Full Text] [Related]
30. Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis.
Narayana JK; Aliberti S; Mac Aogáin M; Jaggi TK; Ali NABM; Ivan FX; Cheng HS; Yip YS; Vos MIG; Low ZS; Lee JXT; Amati F; Gramegna A; Wong SH; Sung JJY; Tan NS; Tsaneva-Atanasova K; Blasi F; Chotirmall SH
Am J Respir Crit Care Med; 2023 Apr; 207(7):908-920. PubMed ID: 36288294
[No Abstract] [Full Text] [Related]
31. Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial.
Platt H; Omole T; Cardona J; Fraser NJ; Mularski RA; Andrews C; Daboul N; Gallagher N; Sapre A; Li J; Polis A; Fernsler D; Tamms G; Xu W; Murphy R; Skinner J; Joyce J; Musey L
Lancet Infect Dis; 2023 Feb; 23(2):233-246. PubMed ID: 36116461
[TBL] [Abstract][Full Text] [Related]
32. Neisseria species as pathobionts in bronchiectasis.
Li L; Mac Aogáin M; Xu T; Jaggi TK; Chan LLY; Qu J; Wei L; Liao S; Cheng HS; Keir HR; Dicker AJ; Tan KS; De Yun W; Koh MS; Ong TH; Lim AYH; Abisheganaden JA; Low TB; Hassan TM; Long X; Wark PAB; Oliver B; Drautz-Moses DI; Schuster SC; Tan NS; Fang M; Chalmers JD; Chotirmall SH
Cell Host Microbe; 2022 Sep; 30(9):1311-1327.e8. PubMed ID: 36108613
[TBL] [Abstract][Full Text] [Related]
33. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.
Stolz D; Mkorombindo T; Schumann DM; Agusti A; Ash SY; Bafadhel M; Bai C; Chalmers JD; Criner GJ; Dharmage SC; Franssen FME; Frey U; Han M; Hansel NN; Hawkins NM; Kalhan R; Konigshoff M; Ko FW; Parekh TM; Powell P; Rutten-van Mölken M; Simpson J; Sin DD; Song Y; Suki B; Troosters T; Washko GR; Welte T; Dransfield MT
Lancet; 2022 Sep; 400(10356):921-972. PubMed ID: 36075255
[No Abstract] [Full Text] [Related]
34. Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron.
van der Straten K; Guerra D; van Gils MJ; Bontjer I; Caniels TG; van Willigen HDG; Wynberg E; Poniman M; Burger JA; Bouhuijs JH; van Rijswijk J; Olijhoek W; Liesdek MH; Lavell AHA; Appelman B; Sikkens JJ; Bomers MK; Han AX; Nichols BE; Prins M; Vennema H; Reusken C; de Jong MD; de Bree GJ; Russell CA; Eggink D; Sanders RW
Immunity; 2022 Sep; 55(9):1725-1731.e4. PubMed ID: 35973428
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing acceptance of influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease.
Saiphoklang N; Phadungwatthanachai J
Hum Vaccin Immunother; 2022 Nov; 18(6):2102840. PubMed ID: 35943223
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic rewiring of pathways related to odour perception in immune cells exposed to SARS-CoV-2
Huoman J; Sayyab S; Apostolou E; Karlsson L; Porcile L; Rizwan M; Sharma S; Das J; Rosén A; Lerm M
Epigenetics; 2022 Dec; 17(13):1875-1891. PubMed ID: 35758003
[TBL] [Abstract][Full Text] [Related]
37. Association of ambient extreme heat with pediatric morbidity: a scoping review.
Uibel D; Sharma R; Piontkowski D; Sheffield PE; Clougherty JE
Int J Biometeorol; 2022 Aug; 66(8):1683-1698. PubMed ID: 35751701
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations.
Li Y; Zhang P; An Z; Yue C; Wang Y; Liu Y; Yuan X; Ma Y; Li K; Yin Z; Wang L; Wang H
Respirology; 2022 Oct; 27(10):844-853. PubMed ID: 35705329
[TBL] [Abstract][Full Text] [Related]
39. TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis.
Berry C; du Cros P; Fielding K; Gajewski S; Kazounis E; McHugh TD; Merle C; Motta I; Moore DAJ; Nyang'wa BT
Trials; 2022 Jun; 23(1):484. PubMed ID: 35698158
[TBL] [Abstract][Full Text] [Related]
40. Parental TB associated with offspring asthma and rhinitis.
López-Cervantes JP; Shigdel R; Accordini S; Mustafa T; Bertelsen RJ; Makvandi-Nejad S; Lerm M; Horsnell W; Svanes C
Int J Tuberc Lung Dis; 2022 Jun; 26(6):544-549. PubMed ID: 35650692
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
